XML 18 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Statements of Cash Flows - USD ($)
 10 Months Ended 12 Months Ended
Dec. 31, 2024
Dec. 31, 2025
Cash Flows from Operating Activities:    
Net income $ 5,129,519 $ 8,309,154
Adjustments to reconcile net income to net cash used in operating activities:    
Payment of expense through IPO Promissory Note – related party 50,736
Interest earned on cash and marketable securities held in Trust Account (5,404,164) (9,919,832)
Unrealized gain on marketable securities held in Trust Account (125,357)
Changes in operating assets and liabilities:    
Prepaid expenses (74,193) 5,349
Other receivable (1,250)
Short-term prepaid insurance (103,180) 49,584
Long-term prepaid insurance (53,596) 53,596
Accrued expenses 109,180 681,957
Net cash used in operating activities (472,305) (820,192)
Cash Flows from Investing Activities:    
Investment of cash into Trust Account (230,000,000)
Net cash used in investing activities (230,000,000)
Cash Flows from Financing Activities:    
Proceeds from sale of Units, net of underwriting discounts paid 226,000,000
Proceeds from sale of Private Placements Warrants 6,000,000
Due from Sponsor (27,340)
Repayment of IPO Promissory Note - related party (307,973)
Payment of offering costs (342,044)
Net cash provided by financing activities 231,322,643
Net Change in Cash 850,338 (820,192)
Cash – Beginning of period 850,338
Cash – End of period 850,338 30,146
Noncash investing and financing activities:    
Deferred fee payable 10,950,000
Deferred offering costs paid through IPO Promissory Note - related party 257,237
Deferred offering costs paid by Sponsor in exchange for issuance of Class B Ordinary Shares $ 25,000